Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24 weeks interim data of the phase 3 MYR301 study

Heiner Wedemeyer, Soo Aleman, Pietro Andreoné, Antje Blank, Maurizia Rossana Brunetto, Pavel Bogomolov, Vladimir Chulanov, Natalia Geyvandova, Gudrun Hilgard, Nina Mamonova, Uta Merle, Mareev Viacheslav, Olga Sagalova, T. Stepanova, Julian Schulze zur Wiesch, S. V Zotov, Stefan Zeuzem, Pietro Lampertico